MedWatch

ALK winds up with Q4 deficit despite record-breaking revenue

ALK's financial report for the last three months of 2020, published Wednesday morning, shows a deficit despite increased revenue and growing tablet sales. The company forecasts 8-12 percent growth in revenue in 2021.

Photo: ALK / PR

Wednesday morning allergy company ALK presented its Q4 fiscal report, which once again shows a deficit in spite of record-breaking revenue.

The fourth quarter's revenue amounted to DKK 991m (USD 161.6m), which is a new record for ALK's Q4. The previous record for the last three months of the year came last fiscal year and showed DKK 883m. In spite of the new record, this figure falls below what analysts had initially forecast.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs